Annual Drug Patent Expirations for LATUDA
Latuda is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for LATUDA.
This drug has forty-seven patent family members in twenty-three countries.
The generic ingredient in LATUDA is lurasidone hydrochloride. One supplier is listed for this compound. Additional details are available on the lurasidone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com